Table 1.
Clinical characteristics
| Total (n = 97) | Nonreactivation (n = 51) | Reactivation (n = 46) | p Value | |
|---|---|---|---|---|
| Age, year | 65 (53–73) | 64 (53–74) | 66 (52.5–71.5) | 0.991 |
| Male gender (%) | 57 (58.8) | 33 (64.7) | 24 (52.2) | 0.224 |
| hospital stay, day | 26 (14.5–47) | 27 (16–53) | 24.5 (13–43.5) | 0.463 |
| ICU stay, day | 16 (10–32.5) | 16 (10–30) | 13.5 (7.5–39.25) | 0.58 |
| CAP (%) | 60 (61.9) | 33 (64.7) | 27 (58.7) | 0.676 |
| Immunosuppression (%) | 36 (37.1) | 12 (23.5) | 24 (52.2) | 0.006 |
| Mechanical ventilation, day | 12 (6–26) | 12 (6–27) | 12 (5–24.25) | 0.641 |
| SOFA score at transfer to ICU | 8 (4.5–12) | 8 (4–12) | 7.5 (5–12) | 0.848 |
| APACHE II score at transfer to ICU | 18 (13–25.5) | 19 (13–24) | 17.5 (13–27.25) | 0.828 |
| NGS testing of Balf | ||||
| Days after admission to hospital, day | 3 (2–11) | 4 (2–9) | 3 (1–14) | 0.675 |
| SOFA score at testing | 8 (5–12) | 8 (4–12) | 8 (6–12) | 0.651 |
| APACHE II score at testing | 19 (15–25.5) | 19 (15–25) | 20 (16–28.5) | 0.296 |
| 28‐day mortality (%) | 41 (42.3) | 17 (33.3) | 24 (52.2) | 0.06 |
Note: Mann–Whitney U‐test and the χ 2 test were used to analyze the clinical characteristics, p < 0.05 were considered statistically significant and shown in bold.
Abbreviations: APACHE II, acute physiology and chronic health evaluation II; CAP, community‐acquired pneumonia; SOFA, sequential organ failure.